Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
US11554170B2 · kind B2 · utility
0Cited by
6References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 15, 2017 |
| Grant date | Jan 17, 2023 |
| Priority date | — |
| Expiry date | Jun 15, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.